Skip to Main Navigation Skip to Page Content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Daminozide: Target Organs and Levels of Evidence for TR-083

Bioassay of Daminozide for Possible Carcinogenicity (CASRN 1596-84-5)

Chemical (Study Title) CASRN	Peer Review Date	Route/Exposure Levels	Study Laboratory
Daminozide 1596-84-5	03/07/1978	Dosed-Feed 0,5000,10000 PPM/50 PER GROUP	Litton Bionetics, Inc.

Levels of Evidence

Male Rats: Negative

Female Rats: Positive

Type	Organ/Tissue (Lesion)
Neoplastic Lesions	Uterus/Cervix: (ADENOCARCINOMA, LEIOMYOSARCOMA)

Male Mice: Equivocal

Type	Organ/Tissue (Lesion)
Neoplastic Lesions	Liver: (CARCINOMA)